{"denoms":[{"counts":[{"groupId":"BG000","value":"123"},{"groupId":"BG001","value":"64"},{"groupId":"BG002","value":"187"}],"units":"Participants"}],"groups":[{"description":"BCMA-naïve participants received subcutaneous elranatamab with a priming regimen of 12 milligrams (mg) on Cycle 1 Day 1 and 32 mg on Cycle 1 Day 4 followed by 76 mg weekly thereafter starting from Cycle 1 Day 8.","id":"BG000","title":"Cohort A"},{"description":"BCMA-exposed participants received subcutaneous elranatamab with a priming regimen of 12 milligrams (mg) on Cycle 1 Day 1 and 32 mg on Cycle 1 Day 4 followed by 76 mg weekly thereafter starting from Cycle 1 Day 8.","id":"BG001","title":"Cohort B"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"9.45","value":"67.1"},{"groupId":"BG001","spread":"9.42","value":"65.7"},{"groupId":"BG002","spread":"9.43","value":"66.6"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"Years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"55"},{"groupId":"BG001","value":"34"},{"groupId":"BG002","value":"89"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"68"},{"groupId":"BG001","value":"30"},{"groupId":"BG002","value":"98"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"18"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"85"},{"groupId":"BG001","value":"34"},{"groupId":"BG002","value":"119"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"27"},{"groupId":"BG001","value":"23"},{"groupId":"BG002","value":"50"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"17"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"11"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"72"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"116"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"26"},{"groupId":"BG001","value":"17"},{"groupId":"BG002","value":"43"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"}],"populationDescription":"Safety analysis set in each cohort included all enrolled participants in the respective cohort who received at least one dose of study intervention."}